Recent Posts

1. 

   Entresto samples. Done?

   Won't be any layoffs in 2024. Novartis will lawyer up with any negative Entresto LOE verdicts and keep the appeals going until 2025. They need the Entresto $$ as long as possible because its paying the bills. I'm stating the obvious but...

   Novartis

   anonymous

   Apr 26, 2024 at 8:55 AM

2. 

   Sotyktu floundering

   How can we establish a foothold when we have zero support? I am not talking about access nor am I talking about money. We have leaders that have never once asked us how they can help. We shoulder EVERYTHING in sales. Would it be fair to ask if...

   Bristol-Myers Squibb

   anonymous

   Apr 26, 2024 at 8:50 AM

3. 

   The 50 REPS at Iveric BIO are better than you!

   Public info can be found with some digging on the fda website- moron

   Astellas

   anonymous

   Apr 26, 2024 at 8:45 AM

4. 

   On behalf of the staff laid off this past quarter…

   first of all, you are owed nothing. Company paid you to do a job, owe you nothing more. But I will explain it to you...Keytruda patent cliff coming, that's billions in revenue lost each year. Plus, the IRA (Inflation Reduction Act) ,is forcing...

   Merck

   anonymous

   Apr 26, 2024 at 8:41 AM

5. 

   The stock price

   What I find shocking is that this company has lasted 175 years. Really, how did we make it this long?

   Pfizer

   anonymous

   Apr 26, 2024 at 8:38 AM

6. 

   Rep alerts otezla

   Rep alerts are as valuable at RTEs but ZS loves to measure them

   Amgen

   anonymous

   Apr 26, 2024 at 8:33 AM

7. 

   Sell Otezla and Keep Sotyktu?

   not sure where the hate is greater, for Sotyktu or for BMY but it's strong will not include on my resume

   Bristol-Myers Squibb

   anonymous

   Apr 26, 2024 at 8:31 AM

8. + Show More